Efficacy Blog Posts

• Medical cannabinoids as a treatment for mental health: helpful or hazardous?

  25 Mar 2026

  • Nora de Bode

  
• Psychedelics and mental health: Can the field deliver on its promise?

  09 Jul 2025

  • Anna Zecharia

  
• Just how good are antipsychotics at preventing relapse? Bridging the efficacy-effectiveness gap

  15 Mar 2024

  • Samei Huda

  
• Individual, group and guided self-help CBT for panic disorder: most delivery formats equally effective, but more evidence needed

  19 Dec 2023

  • Hannah Wallace

  
• Risperidone and aripiprazole: genotype, metabolism and dosage

  11 Mar 2020

  • Dolly Sud

  
• Antipsychotic effectiveness: the numbers don’t lie, check the scoreboard

  14 Mar 2018

  • KCL PNoMH MSc
  • and Derek Tracy

  
• Parent training works for child and adolescent mental health

  19 Jan 2017

  • Tony McGinn

  
• Comparing applets and oranges: barriers to evidence-based practice for app-based psychological interventions

  05 Dec 2016

  • Simon Leigh

  
• Atomoxetine for adult ADHD: the harms outweigh the benefits, according to new systematic review

  11 Dec 2013

  • Liz Hughes

  
• Cochrane review finds quetiapine is equivalent in efficacy to typical antipsychotics and possibly causes fewer side effects

  22 Jul 2013

  • Emma Cernis